Evidence map›Paper›PMID 42122291›Full record

ArticleCancers2026

Correction: Lien et al. Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer.

Tonje G Lien, Hege Oma Ohnstad, Ole Christian Lingjærde, Johan Vallon-Christersson, Marit Aaserud, My Anh Tu Sveli, Åke Borg, On Behalf Of Osbreac, Øystein Garred, Elin Borgen and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Tonje G LienDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953 Nydalen, N-0424 Oslo, Norway.
Hege Oma OhnstadDepartment of Oncology, Division of Cancer Medicine, Oslo University Hospital, P.O. Box 4953 Nydalen, N-0424 Oslo, Norway.
Ole Christian LingjærdeDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953 Nydalen, N-0424 Oslo, Norway.
Johan Vallon-ChristerssonDivision of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381 Lund, Sweden.
Marit AaserudDepartment of Pathology, Oslo University Hospital, P.O. Box 4953 Nydalen, N-0424 Oslo, Norway.
My Anh Tu SveliDepartment of Pathology, Oslo University Hospital, P.O. Box 4953 Nydalen, N-0424 Oslo, Norway.
Åke BorgDivision of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381 Lund, Sweden.
On Behalf Of Osbreac
Øystein GarredDepartment of Pathology, Oslo University Hospital, P.O. Box 4953 Nydalen, N-0424 Oslo, Norway.
Elin BorgenDepartment of Pathology, Oslo University Hospital, P.O. Box 4953 Nydalen, N-0424 Oslo, Norway.
Bjørn NaumeDepartment of Oncology, Division of Cancer Medicine, Oslo University Hospital, P.O. Box 4953 Nydalen, N-0424 Oslo, Norway.
Hege RussnesDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953 Nydalen, N-0424 Oslo, Norway.
Therese SørlieDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953 Nydalen, N-0424 Oslo, Norway.ORCID 0000-0002-5995-2319

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are two text errors in the original publication [...].

Identifiers

PMID42122291
PMCPMC13162605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.